Cargando…
Target-Based Anticancer Indole Derivatives for the Development of Anti-Glioblastoma Agents
Glioblastoma (GBM) is the most aggressive and frequent primary brain tumor, with a poor prognosis and the highest mortality rate. Currently, GBM therapy consists of surgical resection of the tumor, radiotherapy, and adjuvant chemotherapy with temozolomide. Consistently, there are poor treatment opti...
Autores principales: | Salerno, Silvia, Barresi, Elisabetta, Baglini, Emma, Poggetti, Valeria, Da Settimo, Federico, Taliani, Sabrina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056347/ https://www.ncbi.nlm.nih.gov/pubmed/36985576 http://dx.doi.org/10.3390/molecules28062587 |
Ejemplares similares
-
Dual Targeting Topoisomerase/G-Quadruplex Agents in Cancer Therapy—An Overview
por: Salerno, Silvia, et al.
Publicado: (2022) -
Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry
por: Barresi, Elisabetta, et al.
Publicado: (2023) -
Carbonic Anhydrase Activators for Neurodegeneration: An Overview
por: Poggetti, Valeria, et al.
Publicado: (2022) -
The Alpha Keto
Amide Moiety as a Privileged Motif
in Medicinal Chemistry: Current Insights and Emerging Opportunities
por: Robello, Marco, et al.
Publicado: (2021) -
Carbonic anhydrase activation profile of indole-based derivatives
por: Barresi, Elisabetta, et al.
Publicado: (2021)